26 research outputs found
Randomized phase I trial of antigen-specific tolerizing immunotherapy with peptide/calcitriol liposomes in ACPA+ rheumatoid arthritis
BACKGROUND. Antigen-specific regulation of autoimmune disease is a major goal. In seropositive
rheumatoid arthritis (RA), T cell help to autoreactive B cells matures the citrullinated (Cit)
antigen-specific immune response, generating RA-specific V domain glycosylated anti-Cit protein
antibodies (ACPA VDG) before arthritis onset. Low or escalating antigen administration under
“sub-immunogenic” conditions favors tolerance. We explored safety, pharmacokinetics, and
immunological and clinical effects of s.c. DEN-181, comprising liposomes encapsulating self-peptide
collagen II259-273 (CII) and NF-κB inhibitor 1,25-dihydroxycholecalciferol.
METHODS. A double-blind, placebo-controlled, exploratory, single-ascending-dose, phase I trial
assessed the impact of low, medium, and high DEN-181 doses on peripheral blood CII-specific and
bystander Cit64vimentin59-71–specific (Cit-Vim–specific) autoreactive T cell responses, cytokines,
and ACPA in 17 HLA-DRB1*04:01+
or *01:01+
ACPA+
RA patients on methotrexate.
RESULTS. DEN-181 was well tolerated. Relative to placebo and normalized to baseline
values, Cit-Vim–specific T cells decreased in patients administered medium and high doses
of DEN-181. Relative to placebo, percentage of CII-specific programmed cell death 1+
T cells
increased within 28 days of DEN-181. Exploratory analysis in DEN-181–treated patients
suggested improved RA disease activity was associated with expansion of CII-specific and
Cit-Vim–specific T cells; reduction in ACPA VDG, memory B cells, and inflammatory myeloid
populations; and enrichment in CCR7+
and naive T cells. Single-cell sequencing identified T
cell transcripts associated with tolerogenic TCR signaling and exhaustion after low or medium
doses of DEN-181.
CONCLUSION. The safety and immunomodulatory activity of low/medium DEN-181 doses provide
rationale to further assess antigen-specific immunomodulatory therapy in ACPA+
RA
Global data on earthworm abundance, biomass, diversity and corresponding environmental properties
14 p.Earthworms are an important soil taxon as ecosystem engineers, providing a variety of crucial ecosystem functions and services. Little is known about their diversity and distribution at large spatial scales, despite the availability of considerable amounts of local-scale data. Earthworm diversity data, obtained from the primary literature or provided directly by authors, were collated with information on site locations, including coordinates, habitat cover, and soil properties. Datasets were required, at a minimum, to include abundance or biomass of earthworms at a site. Where possible, site-level species lists were included, as well as the abundance and biomass of individual species and ecological groups. This global dataset contains 10,840 sites, with 184 species, from 60 countries and all continents except Antarctica. The data were obtained from 182 published articles, published between 1973 and 2017, and 17 unpublished datasets. Amalgamating data into a single global database will assist researchers in investigating and answering a wide variety of pressing questions, for example, jointly assessing aboveground and belowground biodiversity distributions and drivers of biodiversity change
Global data on earthworm abundance, biomass, diversity and corresponding environmental properties
Publisher Copyright: © 2021, The Author(s).Earthworms are an important soil taxon as ecosystem engineers, providing a variety of crucial ecosystem functions and services. Little is known about their diversity and distribution at large spatial scales, despite the availability of considerable amounts of local-scale data. Earthworm diversity data, obtained from the primary literature or provided directly by authors, were collated with information on site locations, including coordinates, habitat cover, and soil properties. Datasets were required, at a minimum, to include abundance or biomass of earthworms at a site. Where possible, site-level species lists were included, as well as the abundance and biomass of individual species and ecological groups. This global dataset contains 10,840 sites, with 184 species, from 60 countries and all continents except Antarctica. The data were obtained from 182 published articles, published between 1973 and 2017, and 17 unpublished datasets. Amalgamating data into a single global database will assist researchers in investigating and answering a wide variety of pressing questions, for example, jointly assessing aboveground and belowground biodiversity distributions and drivers of biodiversity change.Peer reviewe
Recommended from our members
Global data on earthworm abundance, biomass, diversity and corresponding environmental properties
Earthworms are an important soil taxon as ecosystem engineers, providing a variety of crucial ecosystem functions and services. Little is known about their diversity and distribution at large spatial scales, despite the availability of considerable amounts of local-scale data. Earthworm diversity data, obtained from the primary literature or provided directly by authors, were collated with information on site locations, including coordinates, habitat cover, and soil properties. Datasets were required, at a minimum, to include abundance or biomass of earthworms at a site. Where possible, site-level species lists were included, as well as the abundance and biomass of individual species and ecological groups. This global dataset contains 10,840 sites, with 184 species, from 60 countries and all continents except Antarctica. The data were obtained from 182 published articles, published between 1973 and 2017, and 17 unpublished datasets. Amalgamating data into a single global database will assist researchers in investigating and answering a wide variety of pressing questions, for example, jointly assessing aboveground and belowground biodiversity distributions and drivers of biodiversity change
Hematopoietic stem cell transplantation for adolescents and adults with inborn errors of immunity: an EBMT IEWP study.
peer reviewedAllogeneic hematopoietic stem cell transplantation (HSCT) is the gold standard curative therapy for infants and children with many inborn errors of immunity (IEI), but adolescents and adults with IEI are rarely referred for transplant. Lack of published HSCT outcome data outside small, single-center studies and perceived high risk of transplant-related mortality have delayed the adoption of HSCT for IEI patients presenting or developing significant organ damage later in life. This large retrospective, multicenter HSCT outcome study reports on 329 IEI patients (age range, 15-62.5 years at HSCT). Patients underwent first HSCT between 2000 and 2019. Primary endpoints were overall survival (OS) and event-free survival (EFS). We also evaluated the influence of IEI-subgroup and IEI-specific risk factors at HSCT, including infections, bronchiectasis, colitis, malignancy, inflammatory lung disease, splenectomy, hepatic dysfunction, and systemic immunosuppression. At a median follow-up of 44.3 months, the estimated OS at 1 and 5 years post-HSCT for all patients was 78% and 71%, and EFS was 65% and 62%, respectively, with low rates of severe acute (8%) or extensive chronic (7%) graft-versus-host disease. On univariate analysis, OS and EFS were inferior in patients with primary antibody deficiency, bronchiectasis, prior splenectomy, hepatic comorbidity, and higher hematopoietic cell transplant comorbidity index scores. On multivariable analysis, EFS was inferior in those with a higher number of IEI-associated complications. Neither age nor donor had a significant effect on OS or EFS. We have identified age-independent risk factors for adverse outcome, providing much needed evidence to identify which patients are most likely to benefit from HSCT